Cann Group raises around A$2m but falls short of target by Martin Lane November 28, 2024November 28, 2024 Cann Group has raised approximately A$2 million via a rights issue but fell short of its […]
News in brief: InhaleRx; Hemp Pet; Neurotech International; Cann Group by Martin Lane November 19, 2024November 19, 2024
Cann Group extends deadline for cap raise as investors again told of ‘prosperous future’ by Steve Jones November 6, 2024November 6, 2024
Formal mediation fails to resolve Cann Group and Rua legal dispute but talks continue by Steve Jones October 30, 2024October 30, 2024
Cann Group faces more questions after reporting a bank balance of -$18,000 by Steve Jones October 23, 2024October 23, 2024
Cann Group goes back to investors in bid to raise $6.25m for product expansion by Steve Jones October 8, 2024October 8, 2024
Cann Group cites positive press coverage as possible reason for share price surge by Martin Lane September 30, 2024September 30, 2024
Company news: Cann Group; Helius Therapeutics/Novachem; Elixinol/HFA by Martin Lane September 4, 2024September 5, 2024
